hephaistos.bio
hephaistos.bio is addressing this challenge by combining computational biology, chemistry, machine learning, and structural biology to design custom protein catalysts tailored to specific industrial processes.
hephaistos.bio has raised €161k across 1 funding round from 1 investor, most recently a round in Jun 2026. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€161k
€161,000
Funding rounds
1
Investors
1
distinct backers
Active since
2026-06
latest 2026-06
Funding by year
EUR raised per year · 2026 YTDhephaistos.bio — funding by year — interactive chart.
Data table
| hephaistos.bio — funding by year | |
|---|---|
| 2026 | €161k |
Signals
High confidenceRaise-next likelihood22
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-06-01 | Other | €161k | Venture Kick | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData